Nicox S.A. (OTCMKTS:NICXF) Short Interest Update

Nicox S.A. (OTCMKTS:NICXF) was the recipient of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 151,700 shares, an increase of 1,772.8% from the May 15th total of 8,100 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Nicox Stock Performance

Nicox stock remained flat at $0.44 during midday trading on Friday. Nicox has a 12 month low of $0.44 and a 12 month high of $0.44. The firm has a 50 day moving average of $0.44 and a 200-day moving average of $0.47.

Nicox Company Profile

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.